TRiCares Raises $50m in Series D Financing to Support Upcoming Clinical Milestones

Paris, France and Munich, Germany, July 24, 2024 – TRiCares SAS (“TRiCares”), a privately held pioneer in the field of minimally invasive treatment of tricuspid regurgitation, today announces it has raised $50 million (€46 million) in a Series D financing round.

 

read the press release